Assyro AI

Orange Book product · Brand (NDA)

ADLARITY

DONEPEZIL HYDROCHLORIDE

Brand (NDA)NDA 212304DISCN CORIUM

At a glance

Mar 11, 2022

Approved

Brand (NDA)

Application

Not listed

TE code

11

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 11, 2022

    4 yr 4 mo ago

  2. Today

  3. Patent 12161767 expires

    Listed drug substance patent expiration.

    Dec 30, 2036

    in 10 yr 8 mo

  4. Patent 12168075 expires

    Listed method-of-use patent (U-3334) expiration.

    Dec 30, 2036

    in 10 yr 8 mo

  5. Patent 11679086 expires

    Listed method-of-use patent (U-3334) expiration.

    May 26, 2037

    in 11 yr 1 mo

  6. Patent 10016372 expires

    Listed method-of-use patent (U-3334) expiration.

    Jul 26, 2037

    in 11 yr 3 mo

  7. Patent 10300025 expires

    Listed drug product patent expiration.

    Jul 26, 2037

    in 11 yr 3 mo

  8. Patent 10307379 expires

    Listed drug product patent expiration.

    Jul 26, 2037

    in 11 yr 3 mo

  9. Patent 11103463 expires

    Listed method-of-use patent (U-3334) expiration.

    Jul 26, 2037

    in 11 yr 3 mo

  10. Patent 9993466 expires

    Listed drug product patent expiration.

    Jul 26, 2037

    in 11 yr 3 mo

  11. Patent 11648214 expires

    Listed drug product patent expiration.

    Sep 23, 2037

    in 11 yr 5 mo

  12. Patent 10835499 expires

    Listed drug product patent expiration.

    May 20, 2038

    in 12 yr 1 mo

  13. Patent 10966936 expires

    Listed drug product patent expiration.

    Aug 11, 2038

    in 12 yr 4 mo

Pharmaceutical detail

Active ingredient

DONEPEZIL HYDROCHLORIDE

Strength

5MG/DAY

Dosage form

SYSTEM

Route

TRANSDERMAL

TE code

Not listed

Application

NDA 212304

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (11)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
12161767Dec 30, 2036in 10 yr 8 mo
SubstanceProductU-3334
12168075Dec 30, 2036in 10 yr 8 mo
U-3334
11679086May 26, 2037in 11 yr 1 mo
U-3334
10016372Jul 26, 2037in 11 yr 3 mo
U-3334
10300025Jul 26, 2037in 11 yr 3 mo
Product
10307379Jul 26, 2037in 11 yr 3 mo
Product
11103463Jul 26, 2037in 11 yr 3 mo
U-3334
9993466Jul 26, 2037in 11 yr 3 mo
Product
11648214Sep 23, 2037in 11 yr 5 mo
ProductU-3334
10835499May 20, 2038in 12 yr 1 mo
ProductU-3334
10966936Aug 11, 2038in 12 yr 4 mo
ProductU-3334
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.